Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorCarreño Gago, Lidia
dc.contributor.authorBlazquez Bermejo, Cora
dc.contributor.authorDíaz-Manera, Jordi
dc.contributor.authorCámara Navarro, Yolanda
dc.contributor.authorGallardo, Eduard
dc.contributor.authorMartí Seves, Ramón
dc.contributor.authorTorres Torronteras, Javier
dc.contributor.authorGarcía Arumí, Elena
dc.date.accessioned2019-08-23T05:48:14Z
dc.date.available2019-08-23T05:48:14Z
dc.date.issued2019-06-14
dc.identifier.citationCarreño-Gago L, Blázquez-Bermejo C, Díaz-Manera J, Cámara Y, Gallardo E, Martí R, et al. Identification and Characterization of New RNASEH1 Mutations Associated With PEO Syndrome and Multiple Mitochondrial DNA Deletions. Front Genet. 2019;10:576.
dc.identifier.issn1664-8021
dc.identifier.urihttps://hdl.handle.net/11351/4270
dc.descriptionRNASEH1; Mitochondrial disease; MtDNA
dc.description.abstractMitochondrial DNA (mtDNA) depletion and deletion syndrome encompasses a group of disorders caused by mutations in genes involved in mtDNA replication and maintenance. The clinical phenotype ranges from fatal infantile hepatocerebral forms to mild adult onset progressive external ophthalmoplegia (PEO). We report the case of a patient with PEO and multiple mtDNA deletions, with two new homozygous mutations in RNASEH1. The first mutation (c.487T>C) is located in the same catalytic domain as the four previously reported mutations, and the second (c.258_260del) is located in the connection domain, where no mutations have been reported. In silico study of the mutations predicted only the first mutation as pathogenic, but functional studies showed that both mutations cause loss of ribonuclease H1 activity. mtDNA replication dysfunction was demonstrated in patient fibroblasts, which were unable to recover normal mtDNA copy number after ethidium bromide-induced mtDNA depletion. Our results demonstrate the pathogenicity of two new RNASEH1 variants found in a patient with PEO syndrome, multiple deletions, and mild mitochondrial myopathy.
dc.language.isoeng
dc.publisherFrontiers Media
dc.relation.ispartofseriesFrontiers in Genetics;10
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectUlls - Malalties - Aspectes genètics
dc.subjectADN mitocondrial - Malformacions
dc.subjectRibonucleases
dc.subject.meshOphthalmoplegia
dc.subject.mesh/genetics
dc.subject.meshDNA, Mitochondrial
dc.subject.meshSequence Deletion
dc.subject.meshRibonuclease H
dc.titleIdentification and Characterization of New RNASEH1 Mutations Associated With PEO Syndrome and Multiple Mitochondrial DNA Deletions
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.3389/fgene.2019.00576
dc.subject.decsoftalmoplejía
dc.subject.decs/genética
dc.subject.decsADN mitocondrial
dc.subject.decsdeleción de secuencias
dc.subject.decsribonucleasa H
dc.relation.publishversionhttps://www.frontiersin.org/articles/10.3389/fgene.2019.00576/full
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Carreño-Gago L, Blázquez-Bermejo C, Cámara Y, Martí R, Torres-Torronteras J] Departament de Patologia Mitocondrial i Neuromuscular, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain. [Díaz-Manera J, Gallardo E] Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain. Servei de Neurologia, Malalties Neuromusculars, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Institut de Recerca de HSCSP, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [García-Arumí E] Departament de Patologia Mitocondrial i Neuromuscular, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain. Àrea de Genètica Clínica i Molecular, Hospital Universitari Vall d'Hebron, Barcelona, Spain
dc.identifier.pmid31258551
dc.identifier.wosWOS:000472057300001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record